Drug intelligence / Profile preview

baitouweng decoction + mesalamine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

Baitouweng decoction + mesalamine is a combination therapy consisting of Baitouweng decoction—a traditional Chinese herbal formula—and mesalamine, a standard anti-inflammatory drug used in the management of inflammatory bowel diseases. Baitouweng decoction (also known as Bai Tou Weng Tang) is composed primarily of Pulsatilla chinensis, Coptis chinensis, Phellodendron chinense, and Fraxinus chinensis. It has been traditionally used to treat gut-related disorders such as ulcerative colitis (UC), with demonstrated effects including anti-inflammatory action, modulation of cytokines (e.g., reducing TNF-α, IL-1β, IL-6; increasing IL-10), restoration of intestinal barrier function via tight junction protein expression enhancement, and regulation of tryptophan metabolism through the aryl hydrocarbon receptor pathway[4][6][8]. Mesalamine is a small molecule aminosalicylate that acts locally in the colon to inhibit cyclooxygenase and reduce prostaglandin production—thereby decreasing inflammation. The combination has shown synergistic effects in preclinical models and clinical studies for ulcerative colitis and ulcerative proctitis. The combined regimen more effectively reduces disease activity index scores and inflammatory markers compared to either agent alone[2][3][5]. Mechanistically, this synergy may be due to complementary actions on inflammatory pathways (including inhibition of nuclear factor kappa B p65 activation) and improved repair of mucosal barriers.

Other names
baitouweng tang + mesalamine白头翁汤 + 美沙拉嗪
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))COXNFKB1 (NF-κB1)IL-6R (Interleukin-6 receptor subunit alpha)

Beyond the preview

Go deeper on baitouweng decoction + mesalamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on baitouweng decoction + mesalamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call